Letybo Earns FDA Approval, Hugel Expands Its Global Aesthetic Market Leadership
XTalks
JUNE 17, 2024
RELATED: Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics – Xtalks Life Science Podcast Ep. 134 How Does Letybo Work? Letybo is classified as an acetylcholine release inhibitor and neuromuscular blocking agent.
Let's personalize your content